202 related articles for article (PubMed ID: 34001947)
21. Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis.
Qiu Z; Zhou J; Zhang C; Cheng Y; Hu J; Zheng G
Braz J Med Biol Res; 2018; 51(7):e7220. PubMed ID: 29742265
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.
Yao Y; Li J; Lu Z; Tong A; Wang W; Su X; Zhou Y; Mu B; Zhou S; Li X; Chen L; Gou L; Song H; Yang J; Wei Y
Electrophoresis; 2011 Aug; 32(15):2004-12. PubMed ID: 21739463
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
24. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
26. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.
Wu HJ; Zhuo Y; Zhou YC; Wang XW; Wang YP; Si CY; Wang XH
World J Gastroenterol; 2017 Jul; 23(25):4569-4578. PubMed ID: 28740345
[TBL] [Abstract][Full Text] [Related]
27. Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways.
Qian YY; Li WY; Yan Y; Zhao XY; Yang T; Fang CC; Hou JJ; Liu YQ
Chin J Integr Med; 2019 Nov; 25(11):845-852. PubMed ID: 31127506
[TBL] [Abstract][Full Text] [Related]
28. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
29. iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation.
Niu D; Sui J; Zhang J; Feng H; Chen WN
Proteomics; 2009 Aug; 9(15):3856-68. PubMed ID: 19639599
[TBL] [Abstract][Full Text] [Related]
30. JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells.
Tan G; Qiu M; Chen L; Zhang S; Ke L; Liu J
BMC Cancer; 2017 May; 17(1):376. PubMed ID: 28549433
[TBL] [Abstract][Full Text] [Related]
31. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
32. JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.
McMurtry V; Saavedra JE; Nieves-Alicea R; Simeone AM; Keefer LK; Tari AM
Int J Oncol; 2011 Apr; 38(4):963-71. PubMed ID: 21271218
[TBL] [Abstract][Full Text] [Related]
33. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
34. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
35. Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Zhang Y; Wu SS; Chen XH; Tang ZH; Yu YS; Zang GQ
Med Sci Monit; 2017 Nov; 23():5202-5210. PubMed ID: 29089476
[TBL] [Abstract][Full Text] [Related]
36. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.
She S; Yang M; Hu H; Hu P; Yang Y; Ren H
Cell Physiol Biochem; 2018; 45(2):744-760. PubMed ID: 29414802
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome analysis of signaling pathways targeted by Ellagic acid in hepatocellular carcinoma cells.
Qiu S; Zhong C; Zhao B; Li G; Wang J; Jehan S; Li J; Zhao X; Li D; Sui G
Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129911. PubMed ID: 33862123
[TBL] [Abstract][Full Text] [Related]
38. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
39. HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells.
Duan L; Wu R; Zhang X; Wang D; You Y; Zhang Y; Zhou L; Chen W
Cell Death Dis; 2018 May; 9(6):629. PubMed ID: 29795379
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells.
Liu J; Malavya S; Wang X; Saavedra JE; Keefer LK; Tokar E; Qu W; Waalkes MP; Shami PJ
Genomics; 2009 Jul; 94(1):32-8. PubMed ID: 19348908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
